These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8982688)

  • 1. The anticonvulsant gabapentin decreases firing rates of substantia nigra pars reticulata neurons.
    Bloms-Funke P; Löscher W
    Eur J Pharmacol; 1996 Dec; 316(2-3):211-8. PubMed ID: 8982688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.
    Löscher W; Hönack D; Bloms-Funke P
    Brain Res; 1996 Oct; 735(2):208-16. PubMed ID: 8911659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microdialysis study on the mechanism of action of gabapentin.
    Timmerman W; Bouma M; De Vries JB; Davis M; Westerink BH
    Eur J Pharmacol; 2000 Jun; 398(1):53-7. PubMed ID: 10856447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in firing rate of substantia nigra pars reticulata neurons by valproate: influence of different types of anesthesia in rats.
    Löscher W; Rohlfs A; Rundfeldt C
    Brain Res; 1995 Dec; 702(1-2):133-44. PubMed ID: 8846068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats.
    Rohlfs A; Rundfeldt C; Koch R; Löscher W
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1305-14. PubMed ID: 8667191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats.
    Gernert M; Löscher W
    Eur J Pharmacol; 2001 Nov; 432(1):35-41. PubMed ID: 11734185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.
    Löscher W; Hönack D; Taylor CP
    Neurosci Lett; 1991 Jul; 128(2):150-4. PubMed ID: 1945036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons.
    Waszczak BL; Lee EK; Walters JR
    J Pharmacol Exp Ther; 1986 Nov; 239(2):606-11. PubMed ID: 3095541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons.
    Waszczak BL; Eng N; Walters JR
    Brain Res; 1980 Apr; 188(1):185-97. PubMed ID: 7370752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
    Windels F; Kiyatkin EA
    Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam potentiates GABA-, but not adenosine-mediated, inhibition of neurons of the nigral pars reticulata.
    Waszczak BL
    Neuropharmacology; 1983 Aug; 22(8):953-9. PubMed ID: 6621825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
    Waszczak BL
    Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata.
    Miller AS; Walker JM
    Eur J Pharmacol; 1995 Jun; 279(2-3):179-85. PubMed ID: 7556399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kindling does not cause persistent changes in firing rates or transmitter sensitivities of substantia nigra pars reticulata neurons.
    Waszczak BL; Applegate CD; Burchfiel JL
    Brain Res; 1988 Jul; 455(1):115-22. PubMed ID: 2901283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
    Martin LP; Waszczak BL
    Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subregional changes in discharge rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of epilepsy.
    Gernert M; Fedrowitz M; Wlaz P; Löscher W
    Eur J Neurosci; 2004 Nov; 20(9):2377-86. PubMed ID: 15525279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors.
    Rick CE; Stanford IM; Lacey MG
    Neuroscience; 1995 Dec; 69(3):903-13. PubMed ID: 8596658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine modulation of the effects of gamma-aminobutyric acid on substantia nigra pars reticulata neurons.
    Waszcak BL; Walters JR
    Science; 1983 Apr; 220(4593):218-21. PubMed ID: 6828891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.